CANCER OF THE LUNG, a rare disease at the turn of the century, is today the most common cause of all cancer deaths in males.77 It has become one of the most devastating neoplasms known to medical science.
The earliest records of pulmonary carcinoma are found in the writings of Agricola (A.D. 37-93).69 He and subsequent authors described an unusual disease of the lungs found in men working in the cobalt mines of Schneeberg and Joachimstal. They variously referred to it as tuberculosis, miner's lung and lymphosarcoma of the bronchial glands, but that it was pulmonary carcinoma was not established until Harting and Hesse did so in 1879. As late as 1881, Fraser24 had to apologize to the Medico-Chirurgical Society of Edinburgh for his inability to present more than a single case in which the disease occurred as a primary affection. The first outstanding American contribution to the subject was a monograph by Adler,' 1912 , in which he was able to tabulate only 374 cases.
During the succeeding half-century, cancer of the lung has increased in the United States and most other countries at a phenomenal rate. The death rate during the past 30 years, due to bronchogenic carcinoma, has increased 9533 per cent while the total male cancer death rate in the United States has shown a relatively minor change'9 (see Chart 1) . This rise from obscurity to preeminence merits careful consideration.
A considerable amount of investigation has been and is being done in several countries to determine whether this increase is more apparent than real, owing to factors such as aging of the population, improved diagnostic standards and increasing accuracy of death certification.
The possibility of an increasing incidence due to an aging of the population has been eliminated by a number of statistical observations. When the Reprint requests to: 2369 Torrance Boulevard, Torrance, California 90501. crude mortality rates are corrected to relate to the age-standardized death rates, the factor of aging of the population does not affect the trend. 22 The incidence continues to increase in successively younger age groups.
Some observers have felt that the increasing incidence might be accounted for by better diagnostic standards. However, since the increase is predominantly in the males,55'7' (Chart 2) one would have to assume a difference in diagnostic acumen according to sex. Also, in view of the prominent increase of the epidermoid over the adenocarcinoma type, one would have to assume a difference in the accuracy of diagnosis according to histological interpretation. Review of more than 40 years' au- topsy records from a university medical center wherein diagnostic acumen has been high shows a seven-fold increase in the number of cases of primary lung cancer. 55 Bosner,10 after investigation of the validity of death certification of cancer of the lung in Leeds, concluded that false positive diagnosis was infrequent and that there was no sex difference in the accuracy of certification. Gilliam25 pointed out that even assuming some faulty certification of deaths, such errors could not possibly explain the magnitude of the increased incidence of lung cancer.
The sex incidence of primary lung cancer is greater in males than in females. Kirchoff44 studied a large group of cases from 1900 to 1955. She found the male to female ratio to be approximately 4 to 1 in 1900, and 6 to 1 in 1955. In 1961 Sabour and coworkers,65 reviewing cases from Cairo and London, arrived at a ratio of 9 to 1. It has been shown that this increasing sex ratio is mainly due to the epidermoid and undifferentiated types, the ratio with regards to adenocarcinoma remaining relatively unchanged throughout the years (Chart 2). In view of the startling increase in the incidence of lung cancer, many studies have been undertaken in several countries to determine what factors may be responsible for this "pandemic." Since the total death rate from all other cancers in man has not changed appreciably, the investigations have been narrowed down to environmental factors which come in contact with the bronchial epithelium.
Numerous epidemiological studies of air pollution have been carried out.4611 There is an increase in the incidence of bronchogenic carcinoma associated with heavy occupational exposures to substances such as dust containing radioactive material, chromates, asbestos, tar and soot and nickel.40'41'46 The number of workers employed in such occupations is small in proportion to the total population, and, while important in studying the effects of specific etiologic agents, their influence on 1 Straszewski,72 conducting a retrospective study in Poland, arrived at the same conclusion. He and his associates suggested that the criterion for classification of smokers should be a factor derived from the intensity times the duration. This aspect of the increasing incidence of lung cancer is extremely important in view of the alarming increase in the number of heavy smoking teenagers seen today.
A remarkably high association between cigarette smoking and death rates for men with lung cancer has been found in rural areas as well as in large cities37 (Chart 4). In a comparative study of various communities, Haenzel33 was unable to find any population sub-class that did not have a substantial excess risk among regular cigarette smokers.
The incidence of lung cancer in non-smokers has been studied in relation to industry, occupation and places of residence of large segments of the population.21 Hammond38 found that the lung cancer death rates in non-smokers are extremely low irrespective of whether they lived in urban or rural communities, except for those with heavy occupational exposures to carcinogenic substances. Studies of the incidence of lung cancer in Seventh Day Adventists (non-smokers) who live in the smogridden Los Angeles basin showed a significantly lower lung cancer death rate than that for the rest of the population in that area. 8 Hammond and Garfinkel,36 in a study of smoking habits of men and women, found that the proportion of regular cigarette smokers is much smaller in women than in men. Also the average female smoker was found to start later in life and smoke for fewer years. They were also found to inhale much less than men. It was concluded that the proportion of heavy habitual smokers is much smaller among women than men.
Regarding the incidence of lung cancer in relation to type of smoking, it has been found in at least two studies11'37 that lung cancer is less likely in cigar smokers than in cigarette smokers, and that pipe smokers are almost but not quite on the same level as non-smokers.
We are frequently asked how much good it does to quit after one has been smoking for "years." Best,7 in his Canadian series, and Hammond and Horn37 in the United States series concluded that cutting down from a high to a low amount of cigarette smoking or discontinuing the habit completely resulted in a reduced death rate.
Considerable progress has been made in the laboratory during the past 10 years in confirming an association between the development of lung cancer Approximately 60 per cent of the bronchogenic carcinomas are of the epidermoid type, 25 to 30 per cent are small cell and undifferentiated and 8 to 10 per cent are adenocarcinomas. Listed according to frequency of occurrence, the adenomas, bronchiolo-alveolar carcinomas and mucous gland tumors together represent about 5 per cent of the total. Approximately 75 per cent of the bronchogenic carcinomas arise in the major bronchi and 25 per cent in the peripheral bronchial system. It is generally agreed that over 50 per cent of these primary tumors arise in the upper lobes (slightly more on the right), whereas only 5 per cent arise in the middle lobe. The epidermoid, small cell and undifferentiated types are seen more frequently in the bronchi of men exposed to high concentrations of carcinogenic substances, whereas adenocarcinomas are found in non-smokers and women and do not seem to be related to substances recognized as carcinogens. The tremendous increase in the incidence of lung cancer has been associated with the epidermoid, small cell and undifferentiated groups. These in turn have been found almost exclusively in heavy cigarette smokers.
It has been found that the changes most characteristic in mucosa exposed to irritation by carcinogenic substances are basal cell hyperplasia, squamous metaplasia and carcinoma in situ.5"4 Auerbach,5 making three separate studies of autopsy material over a period of five years, found that people dying of bronchogenic carcinoma showed all types up to and including frank invasive carcinoma. In all three studies, the least changes were found in subjects who did not smoke or smoked only occasionally. He did not find a single case of carcinoma in situ in a non-smoker.
Metastatic spread of these lesions is usually early and extensive because of the copious lymphatic drainage and the enormous volume of blood circulating through the lungs to all other parts of the body. Burford13 reported that examination of the resected specimens of five-year survivors revealed 45 per cent with lymph node involvement and 8 per cent with blood vessel invasion. Pryce62 examined 183 resected carcinomas and found artery and vein invasion in over 40 per cent. The most common sites of lesions metastatic from these tumors are the local and regional lymph nodes, the brain, liver, bones and adrenal glands. Halpert35 reported that 26 per cent to 38 per cent of metastasis is to the brain. It is difficult to predict when metastasis from a bronchogenic carcinoma will occur. According to Goldman26 the extremely well differentiated epidermoid carcinomas may remain localized for long periods, and metastasis then occur only to regional lymph nodes. Burford'3 found that 75 per cent of the resected specimens of five-year survivors were of the epidermoid type. The size of the primary lesion may not be related to its propensity to metastasis. There are cases in which the patient dies of distant metastasis, the primary pulmonary lesion being so small that diagnosis is not established until postmortem examination. Generally speaking, however, the longer one procrastinates and the larger the lung cancer becomes, the higher will be the incidence of distant metastasis with the resulting grim prognosis.
Bronchial adenomas are relatively infrequent tumors, making up less than 5 per cent of all neoplasms of the bronchi.52 They are found with about equal frequency in males and females and are generally seen in patients of a younger age group, the average age for males being 42 and for females 38 years. They do not seem to be related to air pollution or smoking. These tumors arise predominantly in the main stem bronchi, although a few may arise in the secondary and the tertiary bronchial divisions. Endobronchial biopsy is positive in over 75 per cent of the cases. They are usually slow-growing and are quite vascular, accounting for one of the most frequent presenting symptoms, recurrent hemoptysis over a period of months or even years. Many clinicians tend to assume that tumors of this group, because of their classification as adenomas, remain localized within the bronchial lumen in which they arise. Graham27 was the first to stress that these tumors were not entirely benign and that local invasion, lymphatic spread and, rarely, distant metastasis did occur. McBurney49 expressed belief metastasis occurs from about 10 per cent of bronchial adenomas. It is because of this that many pathologists prefer to classify these tumors as Grade I carcinomas. The overall prognosis, however, is good, being better than 80 per cent five-year survival.
The cylindromatous type of bronchial adenomas represent approximately 5 to 10 per cent of this group.50 They are more prone to metastasis and are important because prognosis is considerably poorer than for the true bronchial adenomas.
Bronchiolo-alveolar carcinomas make up a small proportion of primary lung cancers, 1.5 per cent. When solitary, they are usually associated with varying degrees of fibrosis and chronic inflammation, and it is because of this that they are frequently first diagnosed as segmental pneumonitis or as "chronic lung scar." This lesion grows slowly and metastasis is a late occurrence. The cure rate may be as high as 80 per cent when the lesion is surgically removed before lymph node extension has occurred.
Clinical Features
The clinical evolution of lung cancer may be more insidious than that of any other neoplasm. In 1892, Sir William Osler56 commented, "The patient may, indeed, as noted by Walshe, 75 present no symptoms pointing to intrathoracic disease." The first symptoms to appear may be so mild that they are overlooked by the patient and his physician for weeks or even months. They are dependent upon the size, location and pathologic character of the tumor. Those of relatively smaJl size located in the larger bronchi and those in the more peripheral pulmonary parenchyma may remain silent for weeks, months, or even years. In contrast, those obstructing the smaller bronchi or ulcerating early may produce signs and symptoms which could lead to early detection and treatment if the symptoms were acknowledged by the patient and intelligently pursued by the physician. In a retro-spective study of proved lung cancer cases, The Philadelphia Neoplastic Research Project found 38 out of 40 cases in which some symptoms were present before there were demonstrable roentgenographic changes.1'
Cough is one of the earliest and the most frequent symptoms of lung cancer. It is present in approximately 80 per cent of cases. However, because this symptom is associated with so many non-neoplastic conditions such as upper respiratory infections, chronic bronchitis, "smoker's cough," bronchiectasis and various allergic reactions, it is frequently ignored or treated symptomatically until more alarming symptoms develop. It must be borne in mind that cough is a reflex mechanism of the respiratory system produced by irritation of the bronchial tree. A person who does not have a chronic cough generally will seek medical attention much sooner when this symptom appears than a chronic cougher who has a change in the cough he has had for years. Yet it is the heavy smoking chronic coughing male in the fourth, fifth and sixth decades of life who has the highest risk of lung cancer. He should be classified as being in a special "high risk group" and screened at regular intervals with complete radiological and cytological studies. The cough caused by bronchogenic carcinoma usually begins as nonproductive and hacking. As it progresses, clear mucoid and then varying degrees of thick purulent sputum may be produced, depending upon the amount of secondary infection present.
Wheeze is a presenting symptom in only about 20 per cent of the patients with bronchogenic carcinoma. The presence of a wheeze may be detected by someone other than the patient, while he is sleeping in a certain position. Others may notice it only during paroxysmal coughing. Since patients with a chronic productive cough may take a wheeze for granted, they should be warned that when a wheeze cannot be "coughed out" the need for expert evaluation is in order. In any case in which "asthma" rather suddenly develops, whether bilateral or unilateral, careful investigation is warranted.
Hemoptysis is a symptom which usually arouses enough anxiety in a patient to induce him to seek medical care promptly. There are, however, still persons who will conceal this symptom, fearing that it might mean loss of a job or confinement in a sanatorium. Fortunately, with improved health education and the decreasing incidence of tuberculosis, fear of this sort is rapidly disappearing. The three most common causes of hemoptysis are bronchiectasis, tumor and tuberculosis, in that order of frequency of occurrence. Approximately 40 per cent of the bronchogenic carcinomas and 80 per cent of the bronchial adenomas will produce this symptom. The physician should carefully explain to the patient the urgent need for a complete, well organized investigation to establish the exact cause of the bleeding or to at least rule out the presence of tumor. It is important to emphasize that even if a patient has bronchiectasis or tuberculosis, the coexistence of a tumor must still be ruled out. There will be a small proportion of patients in whom all the tests including roentgenographic, bronchoscopic, bronchographic, cytologic and dermatologic will be negative. It is important to follow these patients carefully with periodic examinations to rule out the presence of a tumor which may have been too small to be detected by any of these means at the time of the initial episode of hemoptysis.
Recurrent fever with nonresolving persistent or recurrent pneumonitis, especially in an upper lobe, should be regarded with strong suspicion. This is particularly important in heavy smoking males over the age of 40. Frequently symptoms of general malaise, nocturnal diaphoresis, anorexia, and loss of weight will cause the patient to consult his physician. Physical examination and radiographs will establish the diagnosis of pneumonia, and he may be placed on a therapeutic medical regimen. Decided subjective improvement may occur within a few days, but the patient should never be discharged without follow-up physical examination and repeat of x-ray films of the chest. These studies may reveal only partial resolution of the infiltration, in which case further diagnostic as well as therapeutic measures should be pursued. The physician should not be lulled into a sense of security by initial improvement. If a residual density persist after three to six weeks of a well organized medical regimen, the patient should be given the benefit of a complete examination for thoracic disease, consisting of special x-ray studies including bronchography, bronchoscopy, skin tests and bacteriological and histological studies of the bronchial secretions. An early bronchogenic carcinoma no larger than a few millimeters in diameter may cause atelectasis and pneumonitis of a pulmonary segment large enough to be easily demonstrated by a good x-ray film. If the tumor is diagnosed and surgically removed at that stage, the patient is given a better than 50 per cent chance of cure whereas only a few weeks or months of unwarranted procrastination will reduce the chance of cure to 8 per cent or less.
Dyspnea may be due to any one of a number of diseases which in turn could be caused by an early bronchogenic carcinoma. Spontaneous pneumothorax may be produced by rupture of a bleb produced by emphysematous changes in a lobe or segment resulting from the ball-valve action of a small intrabronchial tumor. Segmental atelectasis with segmental or lobar pneumonitis caused by an early tumor may produce rather pronounced dyspnea in a patient whose pulmonary reserve is compromised by preexisting pulmonary emphysema, fibrosis or bronchiectasis. Dyspnea resulting from pleural effusion may be due to the peripheral pneumonitis and atelectasis caused by a relatively small intrabronchial tumor and may carry a fairly good prognosis, in contrast to the effusion caused by extensive lymphatic and pleural involvement, which invariably carries a grim prognosis. Here again the importance of a complete chest evaluation and a rigid follow-up program is emphatically stressed.
Pain, unfortunately, is usually one of the later manifestations of bronchogenic carcinoma. Yet it is often the symptom which finally induces the patient to seek medical attention. An individual may tolerate a cough or wheeze or recurrent fever with anorexia and weight loss for weeks or months while he tries various home remedies. Unfortunately he may not consult a physician until pain forces him to do so. The pain may be caused by a pleuritis secondary to segmental or lobar pneumonitis with a relatively small tumor, but too often it represents spread of the tumor to involve pleura, nerves, diaphragm or the skeletal system.
The symptoms and signs caused by distant metastasis of lung cancer are important in that they may be the first manifestations of this disease.
Headache, visual changes and changes of equilibrium with Jacksonian convulsions may be due to cerebral metastasis. Hoarseness may be due to recurrent laryngeal nerve involvement. Homer's syndrome (myosis, ptosis and enophthalmos) may represent involvement of the cervical sympathetic ganglia. Persistent arm, neck and shoulder pain may result from involvement of the brachial plexus. Back and chest pain may be due to skeletal metastasis or direct extension of the tumor to the vertebrae or ribs. Dysphagia may be caused by either direct invasion or compression of the esophagus by the bronchogenic carcinoma. Anorexia, many times of a capricious type, may indicate liver metastasis. Edema and cyanosis of the face, neck and upper extremities, with increased pressure in the veins of the neck and arms, is evidence of some compression of the superior vena cava and may represent extensive involvement of the right superior mediastinum. The carcinoid syndrome may be seen with metastatic bronchial adenomas and has been reported rarely in the presence of oat cell carcinomas. Gynecomastia is on rare occasion one of the early symptoms of lung cancer. Hypertrophic pulmonary osteoarthropathy may be associated with bronchogenic carcinoma and has been observed to regress after removal of the primary tumor.59 Diagnosis Early diagnosis of bronchogenic carcinoma is at present one of the most important factors influencing the ultimate prognosis. A constant awareness of the disease with a high index of suspicion on the part of the attending physician is mandatory. The patient should be made aware, through careful discussion and presentation of the facts about lung cancer, of the extreme importance of periodic x-ray and physical examinations of the chest with appropriate follow-up studies of any positive findings. This is especially true for those patients classified in the "high risk" group.
The patient's history should always include a complete review of the respiratory system even though the presenting complaint may be a seemingly unrelated medical, obstetrical or surgical problem. Past and present exposures to the various types of industrial and atmospheric pollutions should be recorded. A history of the patient's smoking habits with reference to duration, intensity and type is of paramount importance. These data along with the patient's age and sex can serve as a baseline in estimating his statistical risk of lung cancer. An accurate record of previous infections, injuries and thoracic roentgenograms may prove of infinite value in the appraisal of subsequent abnormal physical or radiological findings. Nothing can be as valuable to a radiologist or a chest specialist, with the responsibility of interpreting an x-ray density, as a set of previous films for comparison. It is surprising how often patients will have forgotten about previous x-ray examina-tions until specifically questioned about them. Any change in the cough habits of a patient should be included in a good history with special reference to causative factors, periodicity, influence of positional changes, character (dry or productive) and, if productive, the amount, consistency, color and odor of the sputum. In addition it is imperative to make specific queries regarding hemoptysis, wheeze, chest pain, dyspnea, hoarseness and dysphagia.
Radiographic studies are one of the most important means available for early detection of lung cancer. The use of the Mobile Unit Chest Survey film has in general been disappointing from the standpoint of early detection of pulmonary carcinoma.69 One of the reasons for this is that a large proportion of the persons examined are women and children, with relatively few men over the age of 40 included.3' The creation of a false sense of security is probably the outstanding hazard of the usual survey minifilm. A reluctance on the part of an asymptomatic patient to follow through on a suspicious survey finding accounts for a considerable number of failures in surveys of this type.32 This fact again emphasizes the importance of public education and of closer physician-patient relationship. The lesion when at an early enough stage to give a relatively good chance for cure may be completely missed on the single view minifilm, whereas lesions large enough to be detected by this examination are often already far advanced. It has been estimated that approximately 8 per cent of the bronchogenic carcinomas are detected by survey, yet the prognosis may be poorer than for the total number of treated bronchogenic carcinomas.30,60
Fluoroscopic examination as a routine screening diagnostic procedure is unsatisfactory and is mentioned only to be condemned.
It is imperative that at least two views always be taken for an initial diagnostic roentgenogram. Often lesions or areas of segmental atelectasis that cannot be seen on the usual posteroanterior film may be clearly visualized on a lateral film. The only possible justification for taking a single view would be for follow-up studies of a previously diagnosed and localized density.
The importance of giving the radiologist more than just a simple written request for an x-ray examination cannot be overemphasized. When the radiologist knows what is suspected and has a brief resume of the history and positive findings, he may be able to suggest further x-ray studies at the time of the initial x-ray examination and thereby save considerable time in the ultimate diagnosis and subsequent treatment.
Skin tests are important adjuncts in the evaluation of a potential lung carcinoma. The tuberculin and coccidioidin tests are the two usually used, the latter being quite important in the Southwestern states because of the presence of coccidiomycosis. This disease can mimic many pulmonary diseases, including bronchogenic carcinoma. A negative reaction to skin test can be quite significant, but a positive reaction certainly does not rule out carcinoma. It must be kept in mind that this is but a small part of the entire clinical complex, and one should not be given a sense of security by a positive or negative reaction. It is possible for bronchogenic carcinoma to coexist with either active pulmonary tuberculosis or coccidiomycosis.
Bronchoscopy is an essential examination in any patient suspected of having a bronchogenic carcinoma, for approximately 75 per cent of these tumors are found in the major bronchi. The incidence of positive histologic diagnosis by bronchial biopsy ranges from 30 per cent to 50 per cent. In the hands of a skilled endoscopist the procedure can be carried out with little discomfort. It is emphasized that the technical skill alone does not identify a good diagnostic endoscopist. It is mandatory that he possess an intimate anatomic physiologic and pathologic knowledge of the lungs and bronchi. Any patient who is a candidate for pulmonary resection should have bronchoscopic examination, preferably by the thoracic surgeon who is to do the thoracotomy. By direct visualization he can determine the general condition of the major bronchi and the gross intrabronchial extension of the tumor. Involvement of the main carina or both main stem bronchi may indicate inoperability in what would have appeared to be an operable tumor by other criteria, thus saving the patient unnecessary thoracotomy. The surgeon is also given a clue as to the feasibility of lobectomy if, at the time of thoracotomy, that procedure should be indicated. In the patient who has bronchoscopic examination without x-ray evidence of tumor, an early intrabronchial carcinoma may be found, giving a chance for early resection and a good prognosis. Generally speaking, however, a positive diagnosis on bronchoscopic visualization may predict a lower resectability rate by 30 to 50 per cent. Even when the conditions observed at broncho-scopic examination are grossly normal, secretions may be collected for histological and bacteriological studies.
The cytologic examination of sputum and bronchial washings has proved to be a valuable adjunct in the diagnosis of bronchogenic carcinoma when done by experienced cytologists equipped with special laboratory facilities and trained personnel. Ackerman2 pointed out that a false-positive diagnosis can be rendered in patients with atypical pneumonia, pulmonary infarction, lipid pneumonia, mycotic disease or tuberculosis. Green and Umiker45 expressed belief that chronic bronchitis due to heavy smoking may lead to false-positive diagnosis and Koss45 emphasizes that cellular changes produced by irradiation may be extremely difficult to differentiate from those of cancer. It must be remembered cytologic examination usually is negative in the presence of peripheral bronchogenic carcinomas. Accordingly, Overholt57 reported that false-negative cytologic diagnosis occurred in approximately 25 per cent of proved cases of lung cancer in his clinic.
It is emphasized that negative reports do not always mean that a cancer is not present. When a clinician has strong radiographic and clinical evidence of lung cancer, multiple negative cytologic examinations should not influence him, especially if operation is otherwise feasible. When clinical evaluation does not give the impression of lung cancer but cytologic examination of the sputum is positive for malignant cells, a careful correlative clinical and cytologic reevaluation is necessary. It must be remembered that although cytologic examination by trained personnel is a valuable laboratory aid in the diagnosis of lung cancer, it represents but a small part of the diagnostic array. There is still no substitute for careful evaluation, correlation and clinical judgment.
Scalene node biopsy has been found useful in determining metastatic spread to regional lymph nodes. It may account for 15 to 20 per cent of the positive diagnoses. The biopsy should be done even though there are no grossly palpable lymph nodes.39 The presence of positive lymph nodes generally places the patient in the inoperable group, with radiation or chemotherapy or both being offered as palliative measures. However, with the encouraging results recently reported with preoperative irradiation followed in four to six weeks by surgical resection, a new field of therapy has been opened which may have more to offer to these patients than either means alone.
Treatment
In discussing the treatment of lung cancer, Walshe,75 in 1854 stated, "Cancer seated in the lungs is even less under the control of remedies than when occupying some other localities . . . symptoms must be relieved as they occur, by ordinary measures." Salter,66 in 1869, regarding the treatment of lung cancer was said to ". . . doubt if we can in such a case put off the final catastrophe for a single hour."
From these gallant yet grim days until but 30 years ago, the ultimate outlook for the patient with this disease remained the same. With the successful surgical extirpation of a bronchogenic carcinoma by Evarts Graham in 1933,28 a new era in the management of lung cancer began. Since that date thousands of years of human lives have been saved and countless others have been usefully prolonged by effective palliation. Yet it is an alarming fact that there are members of our profession who still cling to the attitude that existed in the middle of the 19th Century. If the defeatist derives his attitude from ignorance he should be educated.
Surgical operation offers the best hope for cure in bronchogenic carcinoma. Of the total number of cases of lung cancer seen, approximately 70 per cent are considered operable. Operability refers to whether or not the patient is a candidate for exploratory thoracotomy; it does not imply resectability. The incidence of operability varies considerably from one clinic to another as well as in different parts of the world. Some clinics have maintained approximately the same rate during the past 25 years, but generally speaking there has been a gradual increase from as low as 30 to 40 per cent to the present figure of 70 per cent. It is hoped that with diligent education of the public, with special emphasis on the "high risk" groups, the operability rate will continue to increase.
In each patient, operability is determined by a number of findings at the time of physical examination. Inoperability is generally considered absolute when any one of the following is present:
* Distant metastasis to the brain, liver or skeletal system. * Terminal disease with little chance to survive any surgical procedure.
* The presence of bilateral pulmonary cancer as seen radiographically or bronchoscopically. * Direct invasion of the mediastinum with involvement of such structures as the esophagus, myocardium or trachea.
* Bloody pleural effusion containing absolute cytologic evidence of pleural invasion. A simple effusion, even if bloody, may be due to local pleural involvement by infection distal to the tumor or to peripheral infarction of the lung itself. Hydrothorax or hemothorax of this type certainly should not in itself contraindicate exploratory thoracotomy.
Findings which once were considered to be an indication of absolute inoperability but are now becoming relative are:
* The presence of neoplastic mediastinal lymphadenopathy. Overholt57 found that 20 per cent of his patients with five-year survival had had positive mediastinal nodes. None of these patients had had preoperative scalene node biopsy or exploratory superior mediastinotomy. He pointed out that undoubtedly some of that 20 per cent group would have had positive biopsy and therefore would have been rejected for intrathoracic exploration. The use of preoperative irradiation followed by resection has improved operability in such cases as well as in cases of superior sulcus tumors with brachial plexus and bone involvement. 67 The superior vena cava syndrome is no longer an absolute contraindication when this therapeutic regimen is utilized.
* Clinical evidence of selective involvement of the recurrent laryngeal or phrenic nerve. Although involvement of these structures usually indicates extensive mediastinal invasion, if there is no corroborative radiographic, bronchoscopic or clinical evidence of mediastinal involvement, one should consider the possibility of a fortuitous local extension which might well be within the limits of respectability. * The patient who appears inoperable because of general debility may be so restored by the judicious use of antibiotics, vigorous bronchial toilet and well planned and administered supportive measures, that in the absence of absolute contraindications, exploration and resection could be accomplished. It should be kept in mind that occasionally major signs and symptoms may be produced by a small lung cancer. The problem of how much lung to remove has received increasing attention during the past 10 years. Ochsner expressed the opinion that pneumonectomy is the treatment of choice when possible. 54 Other observers, however, have shown that the survival rates for lobectomy are as good or in some cases even better than those for pneumonectomy.6"15"16 '57 In addition, the patients have much less pulmonary disability when only a lobe is removed, thus extending the chance for curative resection to those patients for whom operation might have been considered infeasible because of borderline pulmonary reserve. The operative mortality for pneumonectomy is almost twice as great as for lobectomy, 10 to 20 per cent against 5 to 10 per cent.15"1657'63 The morbidity, especially for right pneumonectomy, is considerably greater than for lobectomy. An important point regarding the mortality of pulmonary resection is brought out by Reid. In the cases he reported, in Scotland, the mortality was 23 per cent for pneumonectomy and 13 per cent for lobectomy. He believed that this higher mortality rate than that reported in other countries was due to the unusually high incidence of chronic bronchitis, bronchiectasis and pulmonary emphysema in Scotland.
This important point should be taken into consideration when preparing a patient for pulmonary operation: Since 95 per cent of the patients with lung cancer are heavy smokers with chronic bronchitis, excessive bronchial secretions and obstructive pulmonary emphysema, a strict medical regimen two weeks before operation will appreciably reduce the incidence of operative and postoperative complications. This should include discontinuance of smoking, the use of expectorants, bronchodilators, postural drainage and, when indicated, specific antibiotic therapy. Postoperatively the patient must not be incapacitated by the injudicious use of narcotics and sedatives. Hourly turning, induction of coughing and, when necessary, intra-bronchial suctioning by a diligent, expertly trained special nurse during the first postoperative 24 to 48 hours, can be even more important than the surgical procedure itself in determining the ultimate surgical mortality and morbidity.
Radiation therapy with Cobalt-60 and two-million volt x-ray has received increasing attention during the past decade. Generally speaking, the results with this modality alone have been disappointing, although Smart70 reported a survival rate in selected cases of bronchogenic carcinoma comparable to that for patients treated surgically. 70 Other studies, however, have not agreed with these findings.12'43'53 It is generally agreed that radiation therapy has a definite place in the palliation of inoperable and unresectable lung cancer. It has been of considerable value for the relief of pain and the management of the sequelae of inoperable bronchial obstruction.
The use of subtherapeutic doses of radiation followed in four to six weeks by surgical resection has, to date, offered encouraging results.9'58'67 Five-year statistics are awaited with great hope.
Chemotherapy alone has been of no value as a curative agent in the management of lung cancer.42
Prognosis
The overall five-year survival rate for bronchogenic carcinoma is at present 8 per cent. Mersheimer, reporting in 1960 on the figures of the Cancer End Results Evaluation Program, showed that the five-year survival rate for males in whom the disease was diagnosed before 1950 was 3 per cent as compared with 5 per cent for those after 1950. 51 In cases in which the tumors were classified as localized, the survival rate was better-9 per cent if the diagnosis was before 1950 and 17 per cent if after 1950.
In patients receiving surgical therapy, the fiveyear survival rate for those with localized tumors is 40 to 50 per cent. When the tumor has invaded the regional lymphatics it drops to 15 to 20 per cent (Chart 5).
Studies of surgically treated bronchogenic carcinoma show a low survival rate during the first 30 months, but 75 per cent of the patients who live 30 months will be alive after five years'6'43'57'63 (Chart 5) . It has been found that most of these early deaths are due to distant metastasis, and it is felt that in such cases metastasis either has already occurred or is produced at the time of operation. It will be interesting to see if preoperative irradiation will improve the five-year survival by reducing the number of cases in which distant metastasis is brought about by surgical manipulation of the tumor at the time of resection.
It has been shown that the five-year survival rate for "coin lesions" that turn out to be primary lung cancer is approximately 60 per cent. Overholt reported that carcinoma was found in 40 of 100 cases in which thoracotomy was done for coin lesions. The operative risk during this asymptomatic period is 2 per cent or less. When this risk is compared with the mortality, morbidity and survival rate associated with advanced bronchogenic carcinoma, there seems no question as to the preferred management of a pulmonary density the exact cause of which cannot be determined.
Summary
In summary, we find ourselves involved in a desperate struggle with a disease which continues to increase and to take a high death toll in spite of advancing medical science. Nonetheless, over the years there has been a slow but definite advance by medicine as seen in higher operability and survival rates and lower surgical morbidity and mortality. The * Statistical evidence has been presented to show that cancer of the lung exists as an ever increasing threat to the population.
* Epidemiological evidence has demonstrated a direct association between lung cancer and cigarette smoking.
* Lung cancer can be produced in experimental animals by use of carcinogenic extracts from cigarette smoke.
* It has been shown that in the absence of cigarette smoking, all other factors remaining unchanged, the incidence of lung cancer is reduced.
The fact that lung cancer will develop in some 30,000 Americans this year warrants deep concern. In face of the overwhelming evidence presented throughout the world, one cannot be influenced by the tobacco industry's "The cause of cancer is not known." Many diseases such as cholera, puerperal sepsis, smallpox and scurvy, to name but a few, were being controlled long before their exact causes were known. When carcinogenic agents are found in industrial operations, elaborate detection systems are devised and stringent regulations enforced to protect the workers. The time has come for the tobacco industry to admit the existence of this public health hazard and to take steps to eliminate it. We as physicians have a moral obligation through education to curb the irresponsible advertising of the tobacco industry which encourages teenagers to start using tobacco before they are old enough to clearly evaluate the facts of the situation.
The only hope for the 30,000 Americans a year who have cancer of the lung will be in early detection and prompt, concise treatment, with a never ending endeavor to reduce the procrastination factor. This can be accomplished only through diligent education of the public and an alert, intellectually honest positive attitude on the part of the physician.
